These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25068797)

  • 1. Carbamoylating activity associated with the activation of the antitumor agent laromustine inhibits angiogenesis by inducing ASK1-dependent endothelial cell death.
    Ji W; Yang M; Praggastis A; Li Y; Zhou HJ; He Y; Ghazvinian R; Cincotta DJ; Rice KP; Min W
    PLoS One; 2014; 9(7):e103224. PubMed ID: 25068797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioredoxin reductase is inhibited by the carbamoylating activity of the anticancer sulfonylhydrazine drug laromustine.
    Rice KP; Klinkerch EJ; Gerber SA; Schleicher TR; Kraus TJ; Buros CM
    Mol Cell Biochem; 2012 Nov; 370(1-2):199-207. PubMed ID: 22864532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-dependent general base catalyzed activation rather than isocyanate liberation may explain the superior anticancer efficacy of laromustine compared to related 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine prodrugs.
    Penketh PG; Finch RA; Sauro R; Baumann RP; Ratner ES; Shyam K
    Chem Biol Drug Des; 2018 Jan; 91(1):62-74. PubMed ID: 28636806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antineoplastic efficacy of the prodrug Cloretazine is produced by the synergistic interaction of carbamoylating and alkylating products of its activation.
    Baumann RP; Seow HA; Shyam K; Penketh PG; Sartorelli AC
    Oncol Res; 2005; 15(6):313-25. PubMed ID: 16408696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action of the chloroethylating and carbamoylating moieties of the prodrug cloretazine.
    Ishiguro K; Seow HA; Penketh PG; Shyam K; Sartorelli AC
    Mol Cancer Ther; 2006 Apr; 5(4):969-76. PubMed ID: 16648568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of phosphate and phosphoesters on the decomposition pathway of 1,2-bis(methylsulfonyl)-1-(2-chloroethyhydrazine (90CE), the active anticancer moiety generated by Laromustine, KS119, and KS119W.
    Penketh PG; Shyam K; Zhu R; Baumann RP; Ishiguro K; Sartorelli AC
    Chem Res Toxicol; 2014 May; 27(5):818-33. PubMed ID: 24618018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of O6-alkylguanine-DNA alkyltransferase in cytotoxicity.
    Baumann RP; Shyam K; Penketh PG; Remack JS; Brent TP; Sartorelli AC
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):288-95. PubMed ID: 14685775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU.
    Rice KP; Penketh PG; Shyam K; Sartorelli AC
    Biochem Pharmacol; 2005 May; 69(10):1463-72. PubMed ID: 15857610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of glutathione and glutathione S-transferases on DNA interstrand cross-link formation by 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine, the active anticancer moiety generated by laromustine.
    Penketh PG; Patridge E; Shyam K; Baumann RP; Zhu R; Ishiguro K; Sartorelli AC
    Chem Res Toxicol; 2014 Aug; 27(8):1440-9. PubMed ID: 25012050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox cycling of 1,2-naphthoquinone by thioredoxin1 through Cys32 and Cys35 causes inhibition of its catalytic activity and activation of ASK1/p38 signaling.
    Shinkai Y; Iwamoto N; Miura T; Ishii T; Cho AK; Kumagai Y
    Chem Res Toxicol; 2012 Jun; 25(6):1222-30. PubMed ID: 22587396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner.
    Zhang R; Al-Lamki R; Bai L; Streb JW; Miano JM; Bradley J; Min W
    Circ Res; 2004 Jun; 94(11):1483-91. PubMed ID: 15117824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine residues mediate high-affinity binding of thioredoxin to ASK1.
    Kylarova S; Kosek D; Petrvalska O; Psenakova K; Man P; Vecer J; Herman P; Obsilova V; Obsil T
    FEBS J; 2016 Oct; 283(20):3821-3838. PubMed ID: 27588831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of thioredoxin-1 with siRNA exacerbates apoptosis by activating the ASK1-JNK/p38 pathway in brain of a stroke model rats.
    Wu X; Li L; Zhang L; Wu J; Zhou Y; Zhou Y; Zhao Y; Zhao J
    Brain Res; 2015 Mar; 1599():20-31. PubMed ID: 25541364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unveiling the anticancer potential of Pestalotioprolide E, an unexplored macrolide: Targeting TRXR1-TRX1-ASK1-P38 signaling cascade in triple-negative breast cancer.
    Sarkar R; Paul D; Chatterjee A; Bhattacharya A; Pradhan S; Goswami RK; Sen P
    Toxicol In Vitro; 2024 Oct; 100():105920. PubMed ID: 39173682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor alpha-induced desumoylation and cytoplasmic translocation of homeodomain-interacting protein kinase 1 are critical for apoptosis signal-regulating kinase 1-JNK/p38 activation.
    Li X; Zhang R; Luo D; Park SJ; Wang Q; Kim Y; Min W
    J Biol Chem; 2005 Apr; 280(15):15061-70. PubMed ID: 15701637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trx1/TrxR1 system regulates post-selected DP thymocytes survival by modulating ASK1-JNK/p38 MAPK activities.
    Jin R; Gao Y; Zhang S; Teng F; Xu X; Aili A; Wang Y; Sun X; Pang X; Ge Q; Zhang Y
    Immunol Cell Biol; 2015 Sep; 93(8):744-52. PubMed ID: 25753394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial-specific expression of mitochondrial thioredoxin promotes ischemia-mediated arteriogenesis and angiogenesis.
    Dai S; He Y; Zhang H; Yu L; Wan T; Xu Z; Jones D; Chen H; Min W
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):495-502. PubMed ID: 19150880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MPTP activates ASK1-p38 MAPK signaling pathway through TNF-dependent Trx1 oxidation in parkinsonism mouse model.
    Ray A; Sehgal N; Karunakaran S; Rangarajan G; Ravindranath V
    Free Radic Biol Med; 2015 Oct; 87():312-25. PubMed ID: 26164633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REDOX reaction at ASK1-Cys250 is essential for activation of JNK and induction of apoptosis.
    Nadeau PJ; Charette SJ; Landry J
    Mol Biol Cell; 2009 Aug; 20(16):3628-37. PubMed ID: 19570911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical and structural characterization of the thioredoxin-binding domain of protein kinase ASK1 and its interaction with reduced thioredoxin.
    Kosek D; Kylarova S; Psenakova K; Rezabkova L; Herman P; Vecer J; Obsilova V; Obsil T
    J Biol Chem; 2014 Aug; 289(35):24463-74. PubMed ID: 25037217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.